2019 Update on Medical Overuse: A Review.
2019 Update on Medical Overuse: A Review.
复制标题
DOI:
10.1001/jamainternmed.2019.3842
复制
发表时间:
2019-11-01
影响因子:
39
通讯作者:
Korenstein D
中科院分区:
文献类型:
--
作者:
Morgan DJ;Dhruva SS;Coon ER;Wright SM;Korenstein D
Medical overuse is an important cause of patient harm and medical waste. This structured literature review of English-language articles supplemented by examination of tables of contents of high-impact journals published in 2018 identified articles related to medical overuse. Articles were appraised for their methodologic quality, clinical relevance, and influence on patients. Of 1499 candidate articles, 839 addressed medical overuse. Of these, 117 were deemed to be most significant, with the 10 highest-ranking articles selected by author consensus. The most important articles on medical overuse identified issues with testing, including that procalcitonin does not affect antibiotic duration in patients with lower respiratory tract infection (4.2 vs 4.3 days); incidentalomas are present in 22% to 38% of common magnetic resonance imaging or computed tomography studies; 9% of women dying of stage IV cancer are still screened with mammography; and computed tomography lung cancer screening offers stable benefit and higher rates of harm for patients at lower risk. Articles related to overtreatment reported that urgent care clinics commonly overprescribe antibiotics (in 39% of all visits, patients received antibiotics) and that treatment of subclinical hypothyroidism had no effect on clinical outcomes. Three studies highlighted services that should be questioned, including using opioids for chronic noncancer pain (meta-analysis found no clinically significant benefit), stress ulcer prophylaxis for intensive care unit patients (mortality, 31.1% with pantoprazole vs 30.4% with placebo), and supplemental oxygen for patients with normal oxygen levels (mortality relative risk, 1.21; 95% CI, 1.03–1.43). A policy article found that state medical liability reform was associated with reduced invasive testing for coronary artery disease, including 24% fewer angiograms. The findings suggest that many tests are overused, overtreatment is common, and unnecessary care can lead to patient harm. This review of these 2018 findings aims to inform practitioners who wish to reduce overuse and improve patient care.
登录
查看更多内容
DOI:
10.1056/nejmoa1802670
发表时间:
2018-07-19
期刊:
The New England journal of medicine
影响因子:
--
作者:
Huang DT;Yealy DM;Filbin MR;Brown AM;Chang CH;Doi Y;Donnino MW;Fine J;Fine MJ;Fischer MA;Holst JM;Hou PC;Kellum JA;Khan F;Kurz MC;Lotfipour S;LoVecchio F;Peck-Palmer OM;Pike F;Prunty H;Sherwin RL;Southerland L;Terndrup T;Weissfeld LA;Yabes J;Angus DC;ProACT Investigators
通讯作者:
ProACT Investigators
DOI:
10.1136/bmj.k2357
发表时间:
2018-07-11
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Khera R;Lu Y;Lu J;Saxena A;Nasir K;Jiang L;Krumholz HM
通讯作者:
Krumholz HM
DOI:
10.1177/1049909118792517
发表时间:
2019-03-01
影响因子:
1.9
作者:
Lambden, Jason P.;Chamberlin, Peter;Prigerson, Holly G.
通讯作者:
Prigerson, Holly G.
影响因子:
2.8
作者:
Chamberlin, Peter;Lambden, Jason;Prigerson, Holly G.
通讯作者:
Prigerson, Holly G.
DOI:
10.1001/jama.2015.13764
发表时间:
2015-11-17
期刊:
JAMA
影响因子:
--
作者:
Desai NR;Bradley SM;Parzynski CS;Nallamothu BK;Chan PS;Spertus JA;Patel MR;Ader J;Soufer A;Krumholz HM;Curtis JP
通讯作者:
Curtis JP